PPARδ prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-κB and inhibition of the PKCα/MEK1/2/ERK1/2/AP-1 pathway.
暂无分享,去创建一个
[1] Min Young Kim,et al. Transcriptional up-regulation of antioxidant genes by PPARδ inhibits angiotensin II-induced premature senescence in vascular smooth muscle cells. , 2011, Biochemical and biophysical research communications.
[2] E. Barroso,et al. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1. , 2011, Biochemical pharmacology.
[3] C. Walline,et al. Peroxisome proliferator‐activated receptor δ agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis , 2010, Immunology.
[4] C. Thiemermann,et al. ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-&bgr;/&dgr; ATTENUATES MYOCARDIAL ISCHEMIA/REPERFUSION INJURY IN THE RAT , 2010, Shock.
[5] Won Hee Lee,et al. Irradiation induces regionally specific alterations in pro-inflammatory environments in rat brain , 2010, International journal of radiation biology.
[6] Gang Wu,et al. Anti-inflammatory effects of tanshinone IIA on radiation-induced microglia BV-2 cells inflammatory response. , 2009, Cancer biotherapy & radiopharmaceuticals.
[7] D. Bishop-Bailey,et al. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation. , 2009, Pharmacology & therapeutics.
[8] F. Hsu,et al. The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation. , 2009, International journal of radiation oncology, biology, physics.
[9] S. Kalinin,et al. A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease. , 2009, Current Alzheimer research.
[10] Susan M. Chang,et al. Quality of life in adults with brain tumors: current knowledge and future directions. , 2009, Neuro-oncology.
[11] J. Mitchell,et al. PPAR / Agonists Modulate Platelet Function via a Mechanism Involving PPAR Receptors and Specific Association / Repression of PKC , 2009 .
[12] F. Hsu,et al. PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways. , 2008, Free radical biology & medicine.
[13] W. Wahli,et al. Activation of Peroxisome Proliferator–Activated Receptor β/δ Inhibits Lipopolysaccharide-Induced Cytokine Production in Adipocytes by Lowering Nuclear Factor-κB Activity via Extracellular Signal–Related Kinase 1/2 , 2008, Diabetes.
[14] Didier Grillot,et al. Identification and Characterization of a Selective Peroxisome Proliferator-Activated Receptor β/δ (NR1C2) Antagonist , 2008 .
[15] D. Spitz,et al. Inhibiting catalase activity sensitizes 36B10 rat glioma cells to oxidative stress. , 2007, Free radical biology & medicine.
[16] A. Iwashita,et al. Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor δ-Selective Agonists in Vitro and in Vivo , 2007, Journal of Pharmacology and Experimental Therapeutics.
[17] Jonathan R. Whitlock,et al. Learning Induces Long-Term Potentiation in the Hippocampus , 2006, Science.
[18] D. Bishop-Bailey,et al. Peroxisome proliferator-activated receptors and inflammation. , 2006, Pharmacology & therapeutics.
[19] E. Shaw,et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P. Brown,et al. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] P. Brown,et al. Whole-brain radiotherapy in the management of brain metastasis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] L. Rochette,et al. Peroxisome proliferator-activated receptor δ (PPARδ) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis , 2006 .
[23] E. Shaw,et al. The management of radiation-induced brain injury. , 2006, Cancer treatment and research.
[24] W. Wahli,et al. PPARs in diseases: control mechanisms of inflammation. , 2005, Current medicinal chemistry.
[25] J. de Vellis,et al. Microglia in health and disease , 2005, Journal of neuroscience research.
[26] J. Peters,et al. Peroxisome Proliferator-activated Receptor-β/δ Inhibits Epidermal Cell Proliferation by Down-regulation of Kinase Activity* , 2005, Journal of Biological Chemistry.
[27] W. Wahli,et al. Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes , 2005 .
[28] S. Moreno,et al. Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS , 2004, Neuroscience.
[29] Steven A. Smith,et al. Effect of the peroxisome proliferator‐activated receptor β activator GW0742 in rat cultured cerebellar granule neurons , 2004, Journal of neuroscience research.
[30] S. Kohsaka,et al. Protein kinase Cα requirement in the activation of p38 mitogen-activated protein kinase, which is linked to the induction of tumor necrosis factor α in lipopolysaccharide-stimulated microglia , 2004, Neurochemistry International.
[31] Hiroki Toda,et al. Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.
[32] K. Hole,et al. Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[33] B. Staels,et al. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[34] E. Malle,et al. Vitamin E (alpha-tocopherol) attenuates cyclo-oxygenase 2 transcription and synthesis in immortalized murine BV-2 microglia. , 2003, The Biochemical journal.
[35] J. Sloan,et al. Quality of life measurements: a soft outcome--or is it? , 2002, The American journal of managed care.
[36] Jacqueline P. Williams,et al. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. , 2002, Brain research. Molecular brain research.
[37] M. Lynch,et al. Neuroprotective Effect of Eicosapentaenoic Acid in Hippocampus of Rats Exposed to γ-Irradiation* , 2002, The Journal of Biological Chemistry.
[38] W. Forrester,et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. Gebicke-haerter. Microglia in neurodegeneration: Molecular aspects , 2001, Microscopy research and technique.
[40] T. Herdegen,et al. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration , 2001, Oncogene.
[41] J. Pocock,et al. Microglial signalling cascades in neurodegenerative disease. , 2001, Progress in brain research.
[42] S. Jander,et al. The role of microglia and macrophages in the pathophysiology of the CNS , 1999, Progress in Neurobiology.
[43] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.
[44] M. O’Banion,et al. TNFα and IL-1β mediate intercellular adhesion molecule-1 induction via microglia–astrocyte interaction in CNS radiation injury , 1999, Journal of Neuroimmunology.
[45] C. Marshall,et al. Activation of the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathway by Conventional, Novel, and Atypical Protein Kinase C Isotypes , 1998, Molecular and Cellular Biology.
[46] A. Stalder,et al. Delayed molecular responses to brain irradiation. , 1997, International journal of radiation biology.
[47] E. Neuwelt,et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] Walter Kolch,et al. Protein kinase Cα activates RAF-1 by direct phosphorylation , 1993, Nature.
[49] K. Umesono,et al. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors , 1992, Nature.